| Bioactivity | (+)-Adomeglivant ((+)-LY2409021) is a potent and selective glycogenotropin receptor antagonist with glucose-lowering activity. (+)-Adomeglivant reduces fasting blood glucose levels in both healthy subjects and patients with type 2 diabetes. The use of (+)-Adomeglivant can help investigate the mechanisms of hyperglycemia in type 2 diabetes. The antagonistic effect of (+)-Adomeglivant makes it challenging to assess the metabolic consequences of postprandial hyperglycemia[1]. |
| CAS | 872260-19-0 |
| Formula | C32H36F3NO4 |
| Molar Mass | 555.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes |
(+)-Adomeglivant
CAS: 872260-19-0 F: C32H36F3NO4 W: 555.63
(+)-Adomeglivant ((+)-LY2409021) is a potent and selective glycogenotropin receptor antagonist with glucose-lowering act
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.